Antimicrobial therapy in cancer patients and hematopoietic stem cell transplantation receptors

2Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.
Get full text

Abstract

This manuscript includes the antiinfective therapeutic resources for immunocompromised patients under chemotherapy by cancer or hematopoietic stem cells transplant (HSCT) receptors. The document presents the antimicrobial therapy indicated in the most prevalent clinical situations in this population and the primary and alternative therapy for some specific microorganisms. The clinical situations included in the analysis are: febrile neutropenia without focus, sepsis, infections of the central nervous system, pneumonia, skin and soft tissue infections, neutropenic enterocolitis and urinary tract infection. The therapeutic resources, recommended doses and special precautions for the use of antimicrobial recommended in bacterial, viral, fungal and parasitic infections in this population are described, including the measurement of plasma concentrations of certain drugs in specific situations.

Cite

CITATION STYLE

APA

Santolaya de Pablo, M. E., Álvarez, A. M., Bidart, T., Morales, J., & González, C. (2019). Antimicrobial therapy in cancer patients and hematopoietic stem cell transplantation receptors. Revista Chilena de Infectologia, 36(2), 167–178. https://doi.org/10.4067/S0716-10182019000200167

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free